What is the projected market valuation of the Non-laboratory-based Cannabis Testing Market by 2035?

The market is projected to reach approximately 6.991 USD Billion by 2035. Read More

What was the market valuation of the Non-laboratory-based Cannabis Testing Market in 2024?

In 2024, the market valuation stood at 1.716 USD Billion. Read More

What is the expected CAGR for the Non-laboratory-based Cannabis Testing Market during the forecast period 2025 - 2035?

The expected CAGR for this market is 13.62% during the forecast period. Read More

Which segment is expected to dominate the Non-laboratory-based Cannabis Testing Market by 2035?

Cannabinoid Testing is anticipated to dominate, with a projected valuation of 2.754 USD Billion. Read More

What are the key players in the Non-laboratory-based Cannabis Testing Market?

Key players include CannaSafe, Steep Hill, SC Labs, and others based in the US. Read More

How does the market for Portable Testing Kits compare to other testing methods by 2035?

Portable Testing Kits are expected to reach a valuation of 2.754 USD Billion, leading among testing methods. Read More

What is the projected valuation for Contaminant Testing by 2035?

Contaminant Testing is projected to reach approximately 2.066 USD Billion by 2035. Read More

Which end user segment is expected to see the highest growth in the Non-laboratory-based Cannabis Testing Market?

Cannabis Producers are expected to see the highest growth, with a projected valuation of 2.754 USD Billion. Read More

What is the anticipated market size for Terpene Testing by 2035?

Terpene Testing is anticipated to reach a valuation of 1.164 USD Billion by 2035. Read More

How does the market for Consumer Users compare to other end user segments by 2035?

The market for Consumer Users is projected to reach 0.997 USD Billion, indicating substantial growth. Read More

Non laboratory based Cannabis Testing Market

ID: MRFR/HC/32189-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Non-laboratory-based Cannabis Testing Market Research Report By Test Type (Cannabinoid Testing, Contaminant Testing, Terpene Testing, Pesticide Testing), By End User (Cannabis Producers, Retail Cannabis Stores, Government Regulatory Agencies, Consumer Users), By Testing Method (Portable Testing Kits, Smartphone Applications, Handheld Testing Devices), By Sample Type (Flower Buds, Concentrates, Edibles, Topicals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Non laboratory based Cannabis Testing Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Test Type (USD Billion)
4.1.1 Cannabinoid Testing
4.1.2 Contaminant Testing
4.1.3 Terpene Testing
4.1.4 Pesticide Testing
4.2 Healthcare, BY End User (USD Billion)
4.2.1 Cannabis Producers
4.2.2 Retail Cannabis Stores
4.2.3 Government Regulatory Agencies
4.2.4 Consumer Users
4.3 Healthcare, BY Testing Method (USD Billion)
4.3.1 Portable Testing Kits
4.3.2 Smartphone Applications
4.3.3 Handheld Testing Devices
4.4 Healthcare, BY Sample Type (USD Billion)
4.4.1 Flower Buds
4.4.2 Concentrates
4.4.3 Edibles
4.4.4 Topicals
4.5 Healthcare, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 CannaSafe (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Steep Hill (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 SC Labs (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Green Scientific Labs (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 ProVerde Laboratories (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 MCR Labs (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Pure Analytics (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 PharmaCann (US)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY TEST TYPE
6.4 US MARKET ANALYSIS BY END USER
6.5 US MARKET ANALYSIS BY TESTING METHOD
6.6 US MARKET ANALYSIS BY SAMPLE TYPE
6.7 CANADA MARKET ANALYSIS BY TEST TYPE
6.8 CANADA MARKET ANALYSIS BY END USER
6.9 CANADA MARKET ANALYSIS BY TESTING METHOD
6.10 CANADA MARKET ANALYSIS BY SAMPLE TYPE
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY TEST TYPE
6.13 GERMANY MARKET ANALYSIS BY END USER
6.14 GERMANY MARKET ANALYSIS BY TESTING METHOD
6.15 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
6.16 UK MARKET ANALYSIS BY TEST TYPE
6.17 UK MARKET ANALYSIS BY END USER
6.18 UK MARKET ANALYSIS BY TESTING METHOD
6.19 UK MARKET ANALYSIS BY SAMPLE TYPE
6.20 FRANCE MARKET ANALYSIS BY TEST TYPE
6.21 FRANCE MARKET ANALYSIS BY END USER
6.22 FRANCE MARKET ANALYSIS BY TESTING METHOD
6.23 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE
6.25 RUSSIA MARKET ANALYSIS BY END USER
6.26 RUSSIA MARKET ANALYSIS BY TESTING METHOD
6.27 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
6.28 ITALY MARKET ANALYSIS BY TEST TYPE
6.29 ITALY MARKET ANALYSIS BY END USER
6.30 ITALY MARKET ANALYSIS BY TESTING METHOD
6.31 ITALY MARKET ANALYSIS BY SAMPLE TYPE
6.32 SPAIN MARKET ANALYSIS BY TEST TYPE
6.33 SPAIN MARKET ANALYSIS BY END USER
6.34 SPAIN MARKET ANALYSIS BY TESTING METHOD
6.35 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
6.37 REST OF EUROPE MARKET ANALYSIS BY END USER
6.38 REST OF EUROPE MARKET ANALYSIS BY TESTING METHOD
6.39 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY TEST TYPE
6.42 CHINA MARKET ANALYSIS BY END USER
6.43 CHINA MARKET ANALYSIS BY TESTING METHOD
6.44 CHINA MARKET ANALYSIS BY SAMPLE TYPE
6.45 INDIA MARKET ANALYSIS BY TEST TYPE
6.46 INDIA MARKET ANALYSIS BY END USER
6.47 INDIA MARKET ANALYSIS BY TESTING METHOD
6.48 INDIA MARKET ANALYSIS BY SAMPLE TYPE
6.49 JAPAN MARKET ANALYSIS BY TEST TYPE
6.50 JAPAN MARKET ANALYSIS BY END USER
6.51 JAPAN MARKET ANALYSIS BY TESTING METHOD
6.52 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
6.54 SOUTH KOREA MARKET ANALYSIS BY END USER
6.55 SOUTH KOREA MARKET ANALYSIS BY TESTING METHOD
6.56 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE
6.58 MALAYSIA MARKET ANALYSIS BY END USER
6.59 MALAYSIA MARKET ANALYSIS BY TESTING METHOD
6.60 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
6.61 THAILAND MARKET ANALYSIS BY TEST TYPE
6.62 THAILAND MARKET ANALYSIS BY END USER
6.63 THAILAND MARKET ANALYSIS BY TESTING METHOD
6.64 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE
6.66 INDONESIA MARKET ANALYSIS BY END USER
6.67 INDONESIA MARKET ANALYSIS BY TESTING METHOD
6.68 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE
6.70 REST OF APAC MARKET ANALYSIS BY END USER
6.71 REST OF APAC MARKET ANALYSIS BY TESTING METHOD
6.72 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE
6.75 BRAZIL MARKET ANALYSIS BY END USER
6.76 BRAZIL MARKET ANALYSIS BY TESTING METHOD
6.77 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
6.78 MEXICO MARKET ANALYSIS BY TEST TYPE
6.79 MEXICO MARKET ANALYSIS BY END USER
6.80 MEXICO MARKET ANALYSIS BY TESTING METHOD
6.81 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE
6.83 ARGENTINA MARKET ANALYSIS BY END USER
6.84 ARGENTINA MARKET ANALYSIS BY TESTING METHOD
6.85 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING METHOD
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER
6.93 GCC COUNTRIES MARKET ANALYSIS BY TESTING METHOD
6.94 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER
6.97 SOUTH AFRICA MARKET ANALYSIS BY TESTING METHOD
6.98 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE
6.100 REST OF MEA MARKET ANALYSIS BY END USER
6.101 REST OF MEA MARKET ANALYSIS BY TESTING METHOD
6.102 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
6.103 KEY BUYING CRITERIA OF HEALTHCARE
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF HEALTHCARE
6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
6.109 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
6.110 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion)
6.111 HEALTHCARE, BY END USER, 2024 (% SHARE)
6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
6.113 HEALTHCARE, BY TESTING METHOD, 2024 (% SHARE)
6.114 HEALTHCARE, BY TESTING METHOD, 2024 TO 2035 (USD Billion)
6.115 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
6.116 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.2.2 BY END USER, 2025-2035 (USD Billion)
7.2.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.2.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.3.2 BY END USER, 2025-2035 (USD Billion)
7.3.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.3.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.4.2 BY END USER, 2025-2035 (USD Billion)
7.4.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.4.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.5.2 BY END USER, 2025-2035 (USD Billion)
7.5.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.5.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.6.2 BY END USER, 2025-2035 (USD Billion)
7.6.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.6.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.7.2 BY END USER, 2025-2035 (USD Billion)
7.7.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.7.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.8.2 BY END USER, 2025-2035 (USD Billion)
7.8.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.8.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.9.2 BY END USER, 2025-2035 (USD Billion)
7.9.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.9.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.10.2 BY END USER, 2025-2035 (USD Billion)
7.10.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.10.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.11.2 BY END USER, 2025-2035 (USD Billion)
7.11.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.11.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.12.2 BY END USER, 2025-2035 (USD Billion)
7.12.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.12.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.13.2 BY END USER, 2025-2035 (USD Billion)
7.13.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.13.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.14.2 BY END USER, 2025-2035 (USD Billion)
7.14.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.14.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.15.2 BY END USER, 2025-2035 (USD Billion)
7.15.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.15.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.16.2 BY END USER, 2025-2035 (USD Billion)
7.16.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.16.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.17.2 BY END USER, 2025-2035 (USD Billion)
7.17.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.17.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.18.2 BY END USER, 2025-2035 (USD Billion)
7.18.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.18.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.19.2 BY END USER, 2025-2035 (USD Billion)
7.19.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.19.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.20.2 BY END USER, 2025-2035 (USD Billion)
7.20.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.20.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.21.2 BY END USER, 2025-2035 (USD Billion)
7.21.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.21.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.22.2 BY END USER, 2025-2035 (USD Billion)
7.22.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.22.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.23.2 BY END USER, 2025-2035 (USD Billion)
7.23.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.23.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.24.2 BY END USER, 2025-2035 (USD Billion)
7.24.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.24.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.25.2 BY END USER, 2025-2035 (USD Billion)
7.25.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.25.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.26.2 BY END USER, 2025-2035 (USD Billion)
7.26.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.26.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.27.2 BY END USER, 2025-2035 (USD Billion)
7.27.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.27.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.28.2 BY END USER, 2025-2035 (USD Billion)
7.28.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.28.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.29.2 BY END USER, 2025-2035 (USD Billion)
7.29.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.29.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY TEST TYPE, 2025-2035 (USD Billion)
7.30.2 BY END USER, 2025-2035 (USD Billion)
7.30.3 BY TESTING METHOD, 2025-2035 (USD Billion)
7.30.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Test Type (USD Billion, 2025-2035)

Cannabinoid Testing
Contaminant Testing
Terpene Testing
Pesticide Testing

Healthcare By End User (USD Billion, 2025-2035)

Cannabis Producers
Retail Cannabis Stores
Government Regulatory Agencies
Consumer Users

Healthcare By Testing Method (USD Billion, 2025-2035)

Portable Testing Kits
Smartphone Applications
Handheld Testing Devices

Healthcare By Sample Type (USD Billion, 2025-2035)

Flower Buds
Concentrates
Edibles
Topicals

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓